Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Control Bionics Limited

Market Cap 36.25M 25.47M 22.19M 20.46M 19.24M 36M 2.4B 243M 94.52M 1.18B 95.6M 93.56M 4.1B P/E 2024
-1.4x
P/E 2025 -1.3x
Enterprise Value 36.02M 25.3M 22.05M 20.32M 19.12M 35.76M 2.38B 242M 93.91M 1.18B 94.98M 92.94M 4.07B EV / Sales 2024
1.92x
EV / Sales 2025 1.4x
Free-Float
47.41%
Yield 2024 *
-
Yield 2025 -
1 day-5.38%
1 week+1.15%
Current month+57.14%
1 month+44.26%
3 months+60.00%
6 months+23.94%
Current year+44.26%
1 week 0.08
Extreme 0.085
0.09
1 month 0.06
Extreme 0.055
0.1
Current year 0.05
Extreme 0.05
0.1
1 year 0.03
Extreme 0.026
0.1
3 years 0.03
Extreme 0.026
0.1
5 years 0.03
Extreme 0.026
0.74
10 years 0.03
Extreme 0.026
1.24
Manager TitleAgeSince
Chief Executive Officer - 18/01/2023
Director of Finance/CFO - 12/05/2024
Chief Tech/Sci/R&D Officer - 31/12/2013
Director TitleAgeSince
Chairman - 30/11/2025
Chairman 66 18/11/2025
Director/Board Member - 18/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
-5.38%+1.15%+193.33%-6.38% 27.08M
-4.86%-5.77%+3.63%-38.93% 16.46B
-2.00%-5.85%+25.78%+48.91% 1.6B
+2.04%+0.65%-28.49%+19.58% 1.1B
+4.11%-2.98%-51.75%-84.40% 895M
+5.56%+6.44%-16.36%-51.84% 642M
+0.58%-1.38%-40.36%-58.31% 551M
+3.24%-4.53%+37.29%-54.10% 430M
-1.26%-1.88%-53.89%-62.94% 391M
-3.12%+4.11%-26.69%-25.41% 358M
Average -0.11%+1.03%+4.25%-31.38% 2.25B
Weighted average by Cap. -3.28%-4.51%-0.84%-32.89%

Financials

2024 2025
Net sales 5.35M 3.76M 3.28M 3.02M 2.84M 5.31M 354M 35.92M 13.95M 175M 14.11M 13.81M 605M 6.14M 4.32M 3.76M 3.47M 3.26M 6.1M 407M 41.26M 16.02M 201M 16.21M 15.86M 695M
Net income -5.91M -4.15M -3.62M -3.34M -3.14M -5.87M -392M -39.7M -15.42M -193M -15.6M -15.26M -669M -6.11M -4.29M -3.74M -3.45M -3.24M -6.07M -404M -41.01M -15.93M -199M -16.11M -15.76M -691M
Net Debt -96.95K -68.11K -59.35K -54.71K -51.46K -96.27K -6.42M -651K -253K -3.16M -256K -250K -10.96M -237K -167K -145K -134K -126K -236K -15.71M -1.59M -619K -7.74M -626K -612K -26.83M
Logo Control Bionics Limited
Control Bionics Limited is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses, such as Motor Neurone Disease and Amyotrophic Lateral Sclerosis. Its products include Control Bionics Trilogy Systems, NeuroStrip, NeuroNode, Cosmos Connect and accessories. NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as electromyography output. This output is then sent wirelessly via NeuroNode to a personal computer, enabling speech and other computer-controlled functions like email and texting. Its technology is integrated with eye gaze technology whereby the eye gaze enables a cursor to be moved about a computer screen, driven much like a mouse and the NeuroNode acts like a mouse button. It is commercializing its advancement in its technology, NeuroStrip. It is focused on neuromuscular rehabilitation and athletic optimization.
Employees
-
Date Price Change Volume
18/06/26 0.0880 $ -5.38% 543,447
17/06/26 0.0930 $ +3.33% 423,797
16/06/26 0.0900 $ -1.10% 120,485
15/06/26 0.0910 $ +1.11% 747,940
12/06/26 0.0900 $ +3.45% 844,425

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!